Cantor Fitzgerald Comments on TG Therapeutics, Inc.'s FY2022 Earnings (NASDAQ:TGTX)

Retrieved on: 2021-05-08 15:39:20

Tags for this article:

Click the tags to see associated articles and topics

Cantor Fitzgerald Comments on TG Therapeutics, Inc.'s FY2022 Earnings (NASDAQ:TGTX). View article details on hiswai:

Excerpt

Finally, The Goldman Sachs Group began coverage on TG Therapeutics in a report on Monday, April 26th. They issued a "neutral" rating and a $50.00 ...

Article found on: www.marketbeat.com